Lynn Kohlmeier, MD

Spokane Osteoporosis and Endocrinology, Arthritis Northwest Research
Spokane, Washington, United States

Disclosure information not submitted.

Presentation(s):

• ORF16-07 - Palopegteriparatide Treatment in Adults with Hypoparathyroidism: Final Results of the Phase 3 PaTHway Trial

  Saturday, June 13, 2026
  2:45 PM - 3:00 PM CT

• MON-771 - Improvements in Patient-Reported Outcomes With Eneboparatide in Chronic Hypoparathyroidism Over 1 Year: A Phase 3, Randomized, Placebo-Controlled and Open-Label Study Assessing the Efficacy and Safety of Eneboparatide (CALYPSO)

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT